HUTCHMED (CHINA) LIMITED
(HKEX: 13)

HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.

19.840 -

-0.260 (-1.29%)
Range 19.580 - 20.140   (2.86%)
Open 20.100
Previous Close 20.100
Bid Price 19.830
Bid Volume ('000) 4.5
Ask Price 19.840
Ask Volume ('000) 10
Volume ('000) 7,949.5
Value 157,097,210
Remark -
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events


Top Contributors

Shiori avatar
4203
Followers 169
Posts 5292

Loading Chart...

Please login to view stock data and analysis